GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Wantai Biological Pharmacy Enterprise Co Ltd (SHSE:603392) » Definitions » Financial Strength

Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) Financial Strength : 7 (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Beijing Wantai Biological Pharmacy Enterprise Co Financial Strength?

Beijing Wantai Biological Pharmacy Enterprise Co has the Financial Strength Rank of 7.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.
4. Other debt related ratios.

A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

Beijing Wantai Biological Pharmacy Enterprise Co did not have earnings to cover the interest expense. Beijing Wantai Biological Pharmacy Enterprise Co's debt to revenue ratio for the quarter that ended in Sep. 2024 was 0.12. As of today, Beijing Wantai Biological Pharmacy Enterprise Co's Altman Z-Score is 25.34.


Competitive Comparison of Beijing Wantai Biological Pharmacy Enterprise Co's Financial Strength

For the Biotechnology subindustry, Beijing Wantai Biological Pharmacy Enterprise Co's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Wantai Biological Pharmacy Enterprise Co's Financial Strength Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Wantai Biological Pharmacy Enterprise Co's Financial Strength distribution charts can be found below:

* The bar in red indicates where Beijing Wantai Biological Pharmacy Enterprise Co's Financial Strength falls into.



Beijing Wantai Biological Pharmacy Enterprise Co Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Beijing Wantai Biological Pharmacy Enterprise Co's Interest Expense for the months ended in Sep. 2024 was ¥-1 Mil. Its Operating Income for the months ended in Sep. 2024 was ¥-60 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥148 Mil.

Beijing Wantai Biological Pharmacy Enterprise Co's Interest Coverage for the quarter that ended in Sep. 2024 is

Beijing Wantai Biological Pharmacy Enterprise Co did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

Beijing Wantai Biological Pharmacy Enterprise Co's Debt to Revenue Ratio for the quarter that ended in Sep. 2024 is

Debt to Revenue Ratio=Total Debt (Q: Sep. 2024 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(130.778 + 147.635) / 2328.264
=0.12

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Beijing Wantai Biological Pharmacy Enterprise Co has a Z-score of 25.34, indicating it is in Safe Zones. This implies the Z-Score is strong.

Good Sign:

Altman Z-score of 25.34 is strong.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Wantai Biological Pharmacy Enterprise Co  (SHSE:603392) Financial Strength Explanation

The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

Beijing Wantai Biological Pharmacy Enterprise Co has the Financial Strength Rank of 7.


Beijing Wantai Biological Pharmacy Enterprise Co Financial Strength Related Terms

Thank you for viewing the detailed overview of Beijing Wantai Biological Pharmacy Enterprise Co's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Wantai Biological Pharmacy Enterprise Co Business Description

Traded in Other Exchanges
N/A
Address
No. 31, Science Park Road, Beiqing Road, Changping District, Beijing, CHN, 102206
Beijing Wantai Biological Pharmacy Enterprise Co Ltd is engaged in Research, development, production and sales of in vitro diagnostic reagents, instruments and vaccines.
Executives
Zhao Ling Zhi Directors, senior managers
Zhao Yi Yong senior management
Li Yi Min senior management
Qiu Zi Xin Directors, senior managers
Li Sha Yan senior management
Ye Xiang Zhong Directors, senior managers
Gao Yong Zhong Director

Beijing Wantai Biological Pharmacy Enterprise Co Headlines

No Headlines